Indication
Adult Growth Hormone Deficiency
6 clinical trials
6 products
Clinical trial
A Multicenter, Open-Label, Extension Trial to Investigate Long Term Efficacy and Safety of Lonapegsomatropin in Adults With Growth Hormone DeficiencyStatus: Active (not recruiting), Estimated PCD: 2024-12-01
Product
LonapegsomatropinProduct
SomapacitanClinical trial
A Multi-national, Multi-centre, Prospective, Single-arm, Observational, Non-interventional Post-authorisation Safety Study to Investigate Long-term Safety of Sogroya® (Somapacitan) in Adults With Growth Hormone Deficiency (AGHD) Under Routine Clinical PracticeStatus: , Estimated PCD: 2032-12-15
Clinical trial
Randomized Cross Over Double Blind Versus Placebo Trial Followed by an Open Phase Studying Effect of Norditropin® on Left Ventricular Mass of Growth Hormone Deficient Adult PatientsStatus: Completed, Estimated PCD: 2002-12-01
Product
placeboProduct
somatropinProduct
somavaratanClinical trial
An Open-Label, Long-Term Extension Study of the Safety of Somavaratan (VRS-317) in Adults With Growth Hormone Deficiency (GHD)Status: Terminated, Estimated PCD: 2018-01-11
Clinical trial
Post-Marketing Surveillance (Special Use-results Surveillance on Long-term Use) With Sogroya® A Multi-centre, Prospective, Open Label, Single-arm, Observational, Non-interventional Post-marketing Study to Investigate the Long-term Safety and Clinical Parameters of Sogroya® Therapy in Patients With Adult Growth Hormone Deficiency (AGHD) (Only Severe Case) Under Normal Clinical Practice Conditions in JapanStatus: , Estimated PCD: 2026-12-31
Clinical trial
Growth Hormone Replacement Therapy in Veterans With Gulf War Illness and Adult Growth Hormone DeficiencyStatus: Recruiting, Estimated PCD: 2025-05-01